Experience in patients with hidradenitis suppurativa and COVID-19 symptoms.
作者信息
Galán José Luis, Silvente Catiana, González Mónica, García Claudia, Díez Kevin, Martín María Ángeles, Velázquez Diana, de la Cueva Pablo
机构信息
Hospital Universitario Infanta Leonor, Madrid, Spain.
Hospital Universitario Infanta Leonor, Madrid, Spain.
出版信息
J Am Acad Dermatol. 2020 Oct;83(4):e309-e311. doi: 10.1016/j.jaad.2020.06.986. Epub 2020 Jun 27.
Abstract
摘要
相似文献
1
Experience in patients with hidradenitis suppurativa and COVID-19 symptoms.化脓性汗腺炎合并新冠病毒疾病症状患者的经验
J Am Acad Dermatol. 2020 Oct;83(4):e309-e311. doi: 10.1016/j.jaad.2020.06.986. Epub 2020 Jun 27.
2
Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic.化脓性汗腺炎：COVID-19大流行期间虚拟门诊护理的重要性。
J Am Acad Dermatol. 2020 Jul;83(1):e81-e82. doi: 10.1016/j.jaad.2020.04.142. Epub 2020 May 1.
3
Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations.阿达木单抗在2019冠状病毒病大流行期间用于治疗化脓性汗腺炎：安全性考量
J Am Acad Dermatol. 2020 Jul;83(1):e31. doi: 10.1016/j.jaad.2020.04.030. Epub 2020 Apr 10.
4
Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativa.探究化脓性汗腺炎患者发生重症新型冠状病毒肺炎感染的风险。
J Am Acad Dermatol. 2020 Aug;83(2):e153-e154. doi: 10.1016/j.jaad.2020.05.012. Epub 2020 May 8.
5
Moderate-to-severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.2019年冠状病毒病疫情期间接受全身治疗的中重度化脓性汗腺炎
Dermatol Ther. 2020 Jul;33(4):e13680. doi: 10.1111/dth.13680. Epub 2020 Jun 18.
6
Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.2019冠状病毒病大流行期间银屑病、特应性皮炎（湿疹）、化脓性汗腺炎及痤疮/玫瑰痤疮治疗指南的更新
Dermatol Online J. 2020 Oct 15;26(10):13030/qt0j5150df.
7
Does active smoking worsen Covid-19?主动吸烟会使新冠肺炎恶化吗？
Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28.
8
Important considerations regarding the future management of coronavirus (COVID-19).关于冠状病毒病（COVID-19）未来管理的重要考量因素。
Int J Surg. 2020 Jul;79:6-7. doi: 10.1016/j.ijsu.2020.04.083. Epub 2020 May 5.
9
COVID-19: in the absence of vaccination - 'mask the nation'.新冠疫情：在未接种疫苗的情况下——“全民戴口罩” 。
Future Microbiol. 2020 Jul;15:963-966. doi: 10.2217/fmb-2020-0112. Epub 2020 Jul 17.
10
The Impact of COVID-19 on Italy: A Lesson for the Future.新冠疫情对意大利的影响：未来之鉴。
Int J Occup Environ Med. 2020 Jul 10;11(3):151-152. doi: 10.34172/ijoem.2020.1984. Epub 2020 Mar 30.
引用本文的文献
1
Anemia in patients with hidradenitis suppurativa : A systematic review with meta-analysis.化脓性汗腺炎患者的贫血：系统评价与荟萃分析。
Arch Dermatol Res. 2023 Aug;315(6):1639-1648. doi: 10.1007/s00403-023-02559-9. Epub 2023 Feb 13.
2
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.新冠疫情期间接受生物制剂治疗的银屑病和化脓性汗腺炎患者的皮肤表现
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
3
Low incidence of COVID-19 in hidradenitis suppurativa: How to interpret it?化脓性汗腺炎中新冠病毒感染的低发病率：该如何解读？
Exp Dermatol. 2022 Mar;31(3):435-436. doi: 10.1111/exd.14475. Epub 2021 Nov 3.
4
Clinical Dermatology and COVID-19 Pandemic: Narrative Review.临床皮肤病学与新冠疫情：叙述性综述
Indian J Dermatol. 2021 May-Jun;66(3):246-255. doi: 10.4103/ijd.ijd_463_21.
5
Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis.化脓性汗腺炎患者的2019冠状病毒病并发症：一项多中心分析。
J Dermatol. 2021 Oct;48(10):1619-1621. doi: 10.1111/1346-8138.16073. Epub 2021 Aug 17.
6
COVID-19 in patients with hidradenitis suppurativa.化脓性汗腺炎患者中的新型冠状病毒肺炎
Br J Dermatol. 2021 Jan;184(1):182-184. doi: 10.1111/bjd.19492. Epub 2020 Sep 24.
7
Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic.评估在2019冠状病毒病大流行期间使用阿达木单抗治疗化脓性汗腺炎的风险。
J Am Acad Dermatol. 2020 Dec;83(6):e433-e434. doi: 10.1016/j.jaad.2020.07.086. Epub 2020 Jul 28.
本文引用的文献
1
Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativa.探究化脓性汗腺炎患者发生重症新型冠状病毒肺炎感染的风险。
J Am Acad Dermatol. 2020 Aug;83(2):e153-e154. doi: 10.1016/j.jaad.2020.05.012. Epub 2020 May 8.
2
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.2019年冠状病毒病大流行对接受生物疗法治疗的慢性斑块状银屑病患者的影响：意大利北部的经验。
Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28.
3
COVID-19 and psoriasis: Should we fear for patients treated with biologics?COVID-19 与银屑病：接受生物制剂治疗的患者是否需要担心？
Dermatol Ther. 2020 Jul;33(4):e13434. doi: 10.1111/dth.13434. Epub 2020 May 5.
4
Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations.阿达木单抗在2019冠状病毒病大流行期间用于治疗化脓性汗腺炎：安全性考量
J Am Acad Dermatol. 2020 Jul;83(1):e31. doi: 10.1016/j.jaad.2020.04.030. Epub 2020 Apr 10.
5
Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.化脓性汗腺炎：流行病学、临床表现和发病机制。
J Am Acad Dermatol. 2020 May;82(5):1045-1058. doi: 10.1016/j.jaad.2019.08.090. Epub 2019 Oct 9.
Zotero 插件